New insight into glycation levels and pelvic organ prolapse - A combination of clinical and biochemical studies.

[1]  K. Hua,et al.  Advanced glycation end products decrease collagen I levels in fibroblasts from the vaginal wall of patients with POP via the RAGE, MAPK and NF-κB pathways , 2017, International journal of molecular medicine.

[2]  R. Akhtar,et al.  Advanced glycation products' levels and mechanical properties of vaginal tissue in pregnancy. , 2017, European journal of obstetrics, gynecology, and reproductive biology.

[3]  M. Barber.  Pelvic organ prolapse , 2016, British Medical Journal.

[4]  M. Harma,et al.  Are hypertension and diabetes mellitus risk factors for pelvic organ prolapse? , 2016, European journal of obstetrics, gynecology, and reproductive biology.

[5]  Dongyuan Lü,et al.  Effects of Mechanical Stretching on the Morphology and Cytoskeleton of Vaginal Fibroblasts from Women with Pelvic Organ Prolapse , 2015, International journal of molecular sciences.

[6]  C. Mallen,et al.  Prevalence of genital prolapse symptoms in primary care: a cross-sectional survey , 2015, International Urogynecology Journal.

[7]  K. Hua,et al.  Relationship of advanced glycation end products and their receptor to pelvic organ prolapse. , 2015, International journal of clinical and experimental pathology.

[8]  T. Baer,et al.  Proliferative behavior of vaginal fibroblasts from women with pelvic organ prolapse. , 2014, European journal of obstetrics, gynecology, and reproductive biology.

[9]  Steven Abramowitch,et al.  Changes in the rheological behavior of the vagina in women with pelvic organ prolapse , 2013, International Urogynecology Journal.

[10]  G. Visser,et al.  Advanced glycation end products, measured as skin autofluorescence, during normal pregnancy and pregnancy complicated by diabetes mellitus. , 2012, Diabetes technology & therapeutics.

[11]  Markus Böhm,et al.  Advanced glycation end products , 2012, Dermato-endocrinology.

[12]  M. Mamas,et al.  Role of advanced glycation end products in cardiovascular disease. , 2012, World journal of cardiology.

[13]  A. Puhl,et al.  The effect of hormonal status on the expression of estrogen and progesterone receptor in vaginal wall and periurethral tissue in urogynecological patients. , 2010, European journal of obstetrics, gynecology, and reproductive biology.

[14]  R. Negro,et al.  Age-related pelvic floor modifications and prolapse risk factors in postmenopausal women , 2010, Menopause.

[15]  H. Brölmann,et al.  Changes in connective tissue in patients with pelvic organ prolapse—a review of the current literature , 2009, International Urogynecology Journal.

[16]  Ann Marie Schmidt,et al.  Advanced glycation end products: sparking the development of diabetic vascular injury. , 2006, Circulation.

[17]  F. Piva,et al.  A possible regulatory role of 17β-estradiol and tamoxifen on glyoxalase I and glyoxalase II genes expression in MCF7 and BT20 human breast cancer cells , 2006, Breast Cancer Research and Treatment.

[18]  A. O'Boyle,et al.  Pelvic Organ Support Study (POSST): the distribution, clinical definition, and epidemiologic condition of pelvic organ support defects. , 2005, American journal of obstetrics and gynecology.

[19]  D. Kass,et al.  Advanced glycation end-product cross-link breakers. A novel approach to cardiovascular pathologies related to the aging process. , 2004, American journal of hypertension.

[20]  L. Cardozo,et al.  The role of estrogens in female lower urinary tract dysfunction. , 2003, Urology.

[21]  Z. Urry,et al.  A crucial role for thiol antioxidants in estrogen-deficiency bone loss. , 2003, The Journal of clinical investigation.

[22]  H. Klandorf,et al.  PENTOSIDINE AS A MEASURE OF CHRONOLOGICAL AGE IN WILD BIRDS , 2003 .

[23]  M. Nangaku,et al.  Efficient in vitro lowering of carbonyl stress by the glyoxalase system in conventional glucose peritoneal dialysis fluid. , 2002, Kidney international.

[24]  A. McTiernan,et al.  Pelvic organ prolapse in the Women's Health Initiative: gravity and gravidity. , 2002, American journal of obstetrics and gynecology.

[25]  P. Abrams,et al.  The effect of oestradiol on vaginal collagen metabolism in postmenopausal women with genuine stress incontinence , 2002, BJOG : an international journal of obstetrics and gynaecology.

[26]  Allen J. Bailey,et al.  Molecular mechanisms of ageing in connective tissues , 2001, Mechanisms of Ageing and Development.

[27]  J. Colling,et al.  Epidemiology of Surgically Managed Pelvic Organ Prolapse and Urinary Incontinence , 1997, Obstetrics and gynecology.

[28]  A. Bailey,et al.  The role of glycation cross-links in diabetic vascular stiffening , 1996, Diabetologia.

[29]  P. Abrams,et al.  Changes in metabolism of collagen in genitourinary prolapse , 1996, The Lancet.

[30]  T. Inoue,et al.  Fluorophores from aging human articular cartilage. , 1991, Journal of biochemistry.

[31]  K. Svärdsudd,et al.  Age-related changes in blood pressure. , 1986, Hypertension.

[32]  Y. Wen,et al.  Collagen Metabolism and Turnover in Women with Stress Urinary Incontience and Pelvic Prolapse , 2014, International Urogynecology Journal.

[33]  S. Swift,et al.  Case–Control Study of Etiologic Factors in the Development of Severe Pelvic Organ Prolapse , 2001, International Urogynecology Journal.

[34]  F. Parazzini,et al.  Reproductive factors, family history, occupation and risk of urogenital prolapse. , 1999, European Journal of Obstetrics, Gynecology, and Reproductive Biology.